Search Results for sensor patches

NHSX announces TechForce19 challenge awards (updated), COVID-19 contact tracing app in test for mid-May launch (UK)

...April, and the selection announced on 24 April. Each finalist is being awarded up to £25,000 for further development of their technology systems. The 18 finalists include a number of familiar names to our Readers (who also may be part of these organizations): Feebris, Neurolove, Peppy, Vinehealth, Beam, TeamKinetic, Alcuris MemoHub, Ampersand Health, Aparido, Birdie, Buddi Connect, Just Checking, Peopletoo/Novoville, RIX Research & Media (University of East London), SimplyDo, SureCert, VideoVisit, and Virti. Their systems include checking for the most vulnerable, volunteering apps, mental health support, remote monitoring, home care management, and in-home sensor-based behavioral tracking. Details on each are... Continue Reading

CEO to CEO: TSA’s Alyson Scurfield interview with Tunstall CEO Gordon Sutherland (updated)

...an unexited portfolio company (or ‘unrealised’ in a more delicate term). Another reveal in this conversation is a strategic statement that segments care and presumably the company’s direction into four parts, somewhat like Roman Gaul (which was three or five, depending on the history you’re reading): Reactive care: for instance an alarm bell or PERS press Proactive care: reactive plus social care and well checks Predictive care: sensor-based tracking in the home. Presumably this would be rules-based (i.e. time) on ADLs. Tunstall has added to this Cognitive Care or “Intelli-Care” which would combine presumably #2 and #3 along with other... Continue Reading

Beyond telehealth: sensor-based vital signs monitoring for early coronavirus symptoms being tested in Israel

...Japan for airport arrival testing and, with other tests, during the Ebola event in the US. The dedicated sensors can operate through walls and objects, are not line-of-sight, and are not influenced by lighting. They can map environments and track movements in real-time. The tests are being run with MAFAT (Israel’s Defense Research & Development Directorate) and Israel’s Naval Medical Institute to run real-time monitoring with their personnel to detect early signs of the COVID-19 virus. The Israel National Emergency Team completed an earlier test in which two Vayyar sensor systems were adapted to remotely analyze patient data. Vayyar release.... Continue Reading

Virus-(almost) free news: Cera’s $70m raise, Rx.Health’s RxStitch, remote teledentistry to rescue, Alcuris responds, Caravan buys Wellpepper, and Teladoc’s heavy reading

Keeping calm and carrying on (but taking precautions, staying inside, and keyboarding with hands that resemble gator hide), yes, there IS some news that isn’t entirely about COVID-19: This Editor had put aside the $70 million funding by the UK’s Cera at end of February. What is interesting is that Cera Care is a hybrid–specializing in both supplying home-based care, including dementia care, and providing tech-enabled services for older adults. The funding announcement was timed with the intro of SmartCare, a sensor-based analytics platform that uses machine learning and data analytics on recorded behaviors to personalize care and detect health... Continue Reading

CES roundup: what happened to the excitement around ‘innovation’, robots, VR, and voice assistants?

...your fitness. That is, if you don’t step on it, mistake it for a tennis ball, or your dog doesn’t mistake it for a chew toy. The Charmin Rollbot will deliver a pre-loaded roll when you most need it, navigating through your home, although no capability of climbing stairs in its current concept. The Misty II robot is yet again one of those tabletop robots which are developer toys. This one propels itself and has a camera, a microphone and 3D sensors, and could be repurposed for fall detection, companionship, or to bring you a hot towel. The Lovot is... Continue Reading

The CES circus opens its largest tent yet in health tech, AI, 5G, and more

...ECG and monitor for sleep apnea. The ECG has three leads on the watch on the side of the watch’s bezel and an SpO2 sensor to monitor apneic episodes and oxygen saturation. FDA and CE approval are pending, and when released later this year will cost $249 to $299 depending on size. ZDNet ZDNet and TechRepublic have a running special feature on CES’ big trends for business. The annoyance factor you’ll have to endure is the running CBS commercials for various programs. Mobihealthnews rounds up interesting devices and software such as the Nanit baby sleeping bag that monitors an infant’s... Continue Reading

News roundup: Proteus may be no-teous, DOJ leads on Google-Fitbit, HHS’ mud fight, Leeds leading in health tech, malware miseries, comings and goings

...a substantial number of investors have put in about $487M in funding through a Series H (Crunchbase), including a game-changing investment by Novartis dating back to 2010. Proteus achieved unicorn status about three years ago, but its high-priced pill tracking technology with a pill sensor tracked by a skin-worn monitor reporting into a smartphone has a built-in limited market to expensive medication. Otsuka Pharmaceutical in 2017 partnered with Proteus for an FDA-cleared digital medicine system called Abilify MyCite that basically put an off-patent behavioral drug back into a more expensive tracking methodology. But Proteus remains a great idea on tracking... Continue Reading

WOT with Proteus found equal to or better than DOT in TB medication adherence trial

Implications for administration of tuberculosis and other rigorous therapies. A test conducted by a California university team with tuberculosis (TB) patients comparing Wirelessly Observed Therapy (WOT) administered through Proteus Digital Health’s combination ingestible pill and sensor-based smartphone tracking, versus standard Directly Observed Therapy (DOT), found that WOT was equivalent to DOT in accuracy–and superior to DOT in supporting confirmed daily adherence to TB medications. It was also overwhelmingly preferred by participants. TB is a disease where treatment requires strict adherence to medication protocols over a lengthy treatment course and usually requires a period of direct observation of patient dosage. In... Continue Reading

The confusion within TEC/telehealth between machine learning and AI-powered systems

Defining AI and machine learning terminology isn’t academic, but can influence your business. In reading a straightforward interview about the CarePredict wearable sensor for behavioral modeling and monitoring in an AI-titled publication, this Editor realized that AI–artificial intelligence–as a descriptor is creeping into all sorts of predictive systems which are actually based on machine learning. As TTA has written about previously [TTA 21 Aug], there are many considerations around AI, including the quality of the data being fed into the system, the control over the systems, and the ability to judge the output. Using the AI term sounds so much... Continue Reading

Doro AB acquires Invicta Telecare from Clarion Housing, increasing to nearly 200,000 users (UK)

While this Editor was on holiday, Sweden’s Doro AB increased its presence in the UK with the acquisition of Invicta Telecare, parent of Centra Pulse and Connect. Invicta’s products will join the Welbeing PERS service. which at the time of their acquisition last June had about 75-80,000 users [TTA 7 June 18]. Invicta was sold by Clarion Housing Group, the UK’s largest social housing association, which includes a property development company and a charitable foundation. Invicta’s 2018 revenue was £6.3 million. Like Welbeing, Centra Pulse offers basic and mobile PERS, but also has multi-sensor in-home connected home capability. It is... Continue Reading